Dr. Stephen Hahn Nominated to Head FDA
Hahn is chief medical executive of The University of Texas MD Anderson Cancer Center in Houston
Seriously Ill Medicare Beneficiaries Face Financial Hardship
Majority of respondents rely on help from family and friends, at considerable cost
October 2019 Briefing – Otolaryngology
Here are what the editors at HealthDay consider to be the most important developments in Otolaryngology for October 2019. This roundup includes the latest...
Recommendations Developed to Address Clinician Burnout
Six goals include creation of positive work and learning environments that prevent, reduce burnout
CDC: U.S. Life Expectancy Up Slightly, Mortality Lower in 2017
Report shows decrease in age-adjusted death rates, increase in age-adjusted death rate from overdose
Facebook Launches Preventive Health Tool
Tool created in partnership with American Cancer Society, American College of Cardiology, AHA, CDC
Outcomes Poor With Medical Care From Fraud, Abuse Perpetrators
Mortality and emergency hospitalization rates higher in Medicare beneficiaries with FAP exposures
HPV DNA Identified in Oral Cavity of 6.2 Percent of Teen Girls
Oral HPV detection decreased with number of years since first engaging in sexual activities
AI Model Based on US Classifies Thyroid Nodules by Genetic Risk
Model performance had 45 percent sensitivity, 97 percent specificity, 77.4 percent overall accuracy
FDA: Smokeless Tobacco Snus Can Be Marketed as Less Risky Than Cigarettes
This is the first time the FDA has allowed product marketing of this type
